Patent · US Active

Methods of conditioning patients for T cell therapy

US11491187B2 · kind B2 · utility

1Cited by

4References

15Claims

0Family size

Assignees

Kite Pharma, Inc. · US
The United States of America, as represented by the Secretary, Department of Health and Human Services · US

Inventors

Adrian Bot · Valencia, US
Jeffrey S. Wiezorek · Santa Monica, US
William Go · Santa Monica, US
Rajul JAIN · Santa Monica, US
James N. Kochenderfer · Bethesda, US
Steven A. Rosenberg · Potomac, US

Key dates

Filing date	Apr 10, 2018
Grant date	Nov 8, 2022
Priority date	—
Expiry date	Apr 10, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/03
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides methods of increasing the efficacy of a T cell therapy in a patient in need thereof. The invention includes a method of conditioning a patient prior to a T cell therapy, wherein the conditioning involves administering a combination of cyclophosphamide and fludarabine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.